Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Are the Projected Market Size and Growth Rates for the Actinic Keratosis Market From 2025 To 2029?

The market size for actinic keratosis has experienced a consistent increase over recent years. The market, estimated at $7.95 billion in 2024, is projected to expand to $8.44 billion in 2025, following a compound annual growth rate (CAGR) of 6.1%. The expansion witnessed in the past years has been driven by factors such as escalating exposure to UV radiations, an aging demographic, heightened awareness relating to skin cancer, and the rising incidence of actinic keratosis. Also contributing to the growth are an enhanced healthcare infrastructure, higher disposable incomes, proactive government interventions, and a growing emphasis on preventive skincare.

The market size of actinic keratosis is anticipated to witness substantial growth in the upcoming years, escalating to $10.58 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. Factors such as the advent of inventive therapies, advancements in AI-powered diagnostic instruments, the rising popularity of combination treatments, increased demand for non-invasive procedures, the growing utility of teledermatology, broadening use of photodynamic therapy, heightened awareness of aesthetic outcomes, development of targeted biological treatments, escalating healthcare investment in expanding markets, and an increasing emphasis on early detection and prevention are largely contributing to the growth in the prediction period. Notable trends in the forecast period comprise AI-based diagnostic tools, machine learning for lesion examination, advanced photodynamic therapy systems, wearable UV tracking devices, nanotech-derived drug delivery, 3D imaging for customized treatments, portable phototherapy devices for home use, early detection biosensors, automated software for lesion classification, and hydrogel-based therapeutic systems.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Actinic Keratosis Market?

The rise in serious sunburn cases is set to boost the expansion of the actinic keratosis market. Serious sunburns, instigated by excessive exposure to ultraviolet (UV) radiation, cause intense skin damage, resulting in redness, pain, inflammation, and possible blistering. These sunburns can be attributed to factors such as extended exposure to UV radiation, inadequate sun protection procedures, increased outdoor activities during peak UV hours and temperatures escalating due to climate change. They can lead to actinic keratosis by disrupting the DNA in skin cells via UV radiation, subsequently causing mutations that impede regular cell activity and lead to the emergence of precancerous lesions, particularly with constant or prolonged sun exposure. As an example, in May 2024, Melanoma Focus, a charity in the UK, reported that in 2022-23 there were 201 hospitalizations because of sunburn, which included 89 children and 25 infants less than a year old. The charity also revealed that 66% of UK adults aged between 16-65 recalled being sunburned in their childhood, with 65% enduring serious sunburn and developing blisters at least once. For those with light, pale, or white skin, this figure escalated to 77%. Consequently, the persistent rise in severe sunburn cases is fuelling the actinic keratosis market’s growth.

Which Key Market Segments Comprise the Actinic Keratosis Market and Drive Its Revenue Growth?

The actinic keratosis market covered in this report is segmented –

1) By Treatment Type: Topical Treatment, Surgical Procedure, Photodynamic Therapy, Other Treatment Types

2) By Distribution Channels: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers

3) By End-User: Hospitals, Dermatology Clinics, Spas And Rejuvenation Centers, Homecare Settings, Other End-Users

Subsegments:

1) By Topical Treatment: 5-Fluorouracil (5-FU), Imiquimod, Diclofenac, Ingenol Mebutate, Retinoids

2) By Surgical Procedure: Cryotherapy, Curettage And Electrodessication, Excision

3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy, Methyl Aminolevulinate (MAL) Plus Light Therapy

4) By Other Treatment Types: Laser Therapy, Chemical Peels, Combination Therapies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21077&type=smp

Which Areas Are Leading Regions in the Actinic Keratosis Market Expansion Across the Globe?

North America was the largest region in the actinic keratosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theActinic Keratosis Market Over the Coming Years?

Prominent enterprises in the actinic keratosis market are concentrating their efforts on producing topical ointments, aiming to effectively assail and eradicate precancerous lesions, slash recurrence occurrences, and boost patient adherence with briefer treatment periods and enhanced safety standards. These topical ointments are medicinal creams or gels, that are applied to the affected skin area, with the active component, such as tirbanibulin, that acts by aiming at abnormal keratinocytes to address precancerous lesions. For example, in June 2024, Almirall SA, a biopharmaceutical corporation based in Spain, obtained the US Food and Drug Administration’s (FDA) approval for a supplemental new drug application (sNDA) to broaden the applicability of its drug Klisyri, to up to 100 cm2. Klisyri (tirbanibulin) 1% ointment is a microtubule inhibitor, created to halt the growth of abnormal keratinocytes, thus effectively diminishing the number and dimensions of precancerous lesions for the remediation of actinic keratosis (AK) on the face or scalp.

View the full report here:

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

How Is the Actinic Keratosis Market Conceptually Defined?

Actinic keratosis (AK), also known as solar keratosis, is a common precancerous skin condition that occurs due to prolonged exposure to ultraviolet (UV) radiation from the sun or artificial sources leading to rough, scaly or crusty patches on sun-exposed areas of the skin such as the face, scalp, hands and arms. It is considered an early stage of squamous cell carcinoma (SCC) and requires treatment to prevent progression. Regular skin checks and protection from sun exposure are essential for managing and preventing the development of actinic keratosis.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21077

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model